Camphor and Lopressor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Camphor (camphor) and Lopressor (metoprolol tartrate). Common drug interactions include abdominal pain among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Camphor and Lopressor. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Camphor?

Camphor has active ingredients of camphor. eHealthMe is studying from 627 Camphor users. Check the latest studies of Camphor.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.



On Aug, 06, 2026

16 people who take Camphor and Lopressor together, and have interactions are studied.

Camphor and Lopressor drug interactions.

What are the common drug interactions of Camphor and Lopressor, by gender? *:

female:

  1. Abdominal pain
  2. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  3. Encephalopathy (functioning of the brain is affected by some agent or condition)
  4. Inflammatory bowel disease
  5. Renal tubular necrosis (death of kidney tubules)
  6. Dyspnoea (difficult or laboured respiration)
  7. Hypervolaemia (abnormally increased volume of blood)
  8. Pneumonia
  9. Urinary tract infection
  10. Defaecation urgency (a sudden compelling urge to defecate)

male:

  1. Chronic kidney disease
  2. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  3. Diarrhoea
  4. Emotional distress
  5. Hip arthroplasty
  6. Pain
  7. Pyrexia (fever)
  8. Renal impairment (severely reduced kidney function)
  9. Tooth loss
  10. Bacteraemia (presence of bacteria in the blood)

What are the common drug interactions of Camphor and Lopressor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  3. Inflammatory bowel disease
  4. Defaecation urgency (a sudden compelling urge to defecate)
  5. Diarrhoea
  6. Dyspepsia (indigestion)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Frequent bowel movements
  9. Incontinence (lack of moderation or self-control)
  10. Nausea (feeling of having an urge to vomit)

40-49:

  1. Chronic kidney disease
  2. Osteonecrosis (death of bone)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Blood creatinine increased
  6. Bone density decreased
  7. Emotional distress
  8. Hip arthroplasty
  9. Pain
  10. Renal impairment (severely reduced kidney function)

50-59:

n/a

60+:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Hypotension (abnormally low blood pressure)
  3. Pneumonia
  4. Urinary tract infection
  5. Bacteraemia (presence of bacteria in the blood)
  6. Cellulitis (infection under the skin)
  7. Osteomyelitis (infection of bone)
  8. Pneumonia cytomegaloviral (cmv pneumonia is caused by a member of a group of herpes-type viruses)
  9. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  10. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

What are the existing conditions these people have? *

  1. Hypersensitivity: 4 people, 25.00%
  2. Itching: 3 people, 18.75%
  3. Nausea (feeling of having an urge to vomit): 3 people, 18.75%
  4. Nausea And Vomiting: 3 people, 18.75%
  5. Diarrhea: 2 people, 12.50%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
  7. Flatulence (flatus expelled through the anus): 2 people, 12.50%
  8. Fever: 2 people, 12.50%
  9. Febrile Neutropenia (fever with reduced white blood cells): 2 people, 12.50%
  10. Dry Eyes (lack of adequate tears): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Camphor and Lopressor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Camphor and Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Camphor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Camphor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lopressor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on camphor and metoprolol tartrate (the active ingredients of Camphor and Lopressor, respectively), and Camphor and Lopressor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: